Aspen Aerogels, Inc. (ASPN) stock plummeted 23.58% in after-hours trading on Wednesday following the release of its fourth-quarter 2024 financial results and disappointing first-quarter 2025 guidance.
While the company's Q4 revenue of $123.1 million beat consensus estimates of $120.8 million, and its Q4 EPS of $0.14 also topped expectations of $0.09, the market reacted negatively to its Q1 2025 guidance.
Aspen Aerogels provided a weak Q1 2025 revenue guidance range of $75 million to $95 million, significantly below the consensus estimate of $104.22 million. Additionally, the company's Q1 EPS guidance range of ($0.18) to $0.00 fell short of the consensus estimate of $0.08.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。